Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PFE crawled time : 23:00 save search
Update: Annual Changes to the Nasdaq-100® Index
Published: 2023-12-12 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: -8.05%
H: 1.71%
C: 1.45%
TTWO 4 | $142.19 0.33% 200K
|
Consumer Durables
|
| O: 2.51%
H: 1.8%
C: 1.23%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.03%
H: 0.01%
C: -0.08%
NDAQ | $60.93 -0.26% 510K
|
Finance
|
| O: 0.11%
H: 4.08%
C: 3.98%
100 index
Rising R&D Investment and Government Support Fuel Expansion of Global Duchenne Muscular Dystrophy Drugs Market
Published: 2023-10-24 (Crawled : 23:00) - prnewswire.com
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.1%
H: 1.77%
C: 0.89%
LLY | News | $731.46 -1.91% 700K
|
Health Technology
|
| O: 2.75%
H: 0.46%
C: -1.76%
BMY | $48.64 -0.71% 2.3M
|
Health Technology
|
| O: -0.18%
H: 1.34%
C: 1.05%
PTCT | News S | $25.15 -1.02% 99K
|
Health Technology
|
| O: -1.34%
H: 2.23%
C: 1.62%
LXRX | $1.6 -0.62% 750K
|
Health Technology
|
| O: -1.68%
H: 0.85%
C: -2.99%
expansion global duchenne market
Global Vulvovaginal Candidiasis Treatment Market Research Report 2023-2028 - Demand for Cost-effective Vulvovaginal Candidiasis Treatment Soars with Growing Geriatric Population
Published: 2023-10-04 (Crawled : 23:00) - prnewswire.com
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: 0.59%
H: 0.29%
C: 0.22%
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.42%
H: 0.99%
C: 0.06%
SCYX | $1.55 22K
|
Health Technology
|
| O: 0.45%
H: 4.04%
C: 0.45%
CDTX | News | $10.65 3.9% 24K
|
Health Technology
|
| O: 0.39%
H: 10.33%
C: 3.9%
report treatment candidiasis research global growing market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $24.54 1.15% 260K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.27 -1.53% 2.3M
|
Health Technology
| Email alert
Add to watchlist
NBIX | News M | $139.34 -0.53% 230K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 480
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $65.26 5.9K
|
Manufacturing
| Email alert
Add to watchlist
UCBJF | $128.725 750
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $140.3 1.5K
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.23 -1.12% 300K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 52K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.515 0.24% 820K
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.64 -0.71% 2.3M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.93 0.11% 2.3M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $731.46 -1.91% 700K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.82 -1.82% 510K
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $168.1 -0.85% 670K
|
Health Technology
| Email alert
Add to watchlist
report business life global therapeutics
FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)
Published: 2023-02-10 (Crawled : 23:00) - biospace.com/
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.37%
H: 1.1%
C: 0.87%
cibinqo fda drug application
ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: -0.28%
H: 0.19%
C: -0.44%
results
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Published: 2022-03-15 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | News | $88.55 0.07% 62K
|
Health Technology
|
| O: 1.63%
H: 11.55%
C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Published: 2021-10-26 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.39%
H: 0.23%
C: -1.13%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BNTX | News | $88.55 0.07% 62K
|
Health Technology
|
| O: -0.4%
H: 1.16%
C: -5.35%
covid fda children vaccine merge emergency use authorization
Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease
Published: 2021-07-08 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.71%
H: 1.44%
C: 0.2%
ABBV | News | $168.1 -0.85% 670K
|
Health Technology
|
| O: -0.04%
H: 0.88%
C: 0.24%
BIIB | $202.05 4.59% 1.1M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
disease genetic collaboration rare
Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206
Published: 2021-06-30 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.03%
H: 1.17%
C: 1.0%
SPRO | $1.435 43K
|
Health Technology
|
| O: 19.27%
H: 2.94%
C: -1.56%
license
Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia
Published: 2021-06-16 (Crawled : 23:00) - biospace.com/
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.08%
H: 0.56%
C: -0.81%
covid brazil
Insights on the Meningococcal Vaccine Global Market to 2026 - Featuring GlaxoSmithKline, Pfizer and Sanofi Among Others
Published: 2021-04-20 (Crawled : 23:00) - prnewswire.com
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.28%
H: 1.35%
C: 1.0%
GSK | News | $40.73 -1.24% 360K
|
Health Technology
|
| O: 0.72%
H: 0.93%
C: 0.74%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.48%
H: 0.59%
C: 0.4%
vaccine
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
Published: 2021-02-17 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: -0.32%
H: 0.28%
C: -0.63%
BNTX | News | $88.55 0.07% 62K
|
Health Technology
|
| O: -4.9%
H: 5.19%
C: 4.31%
covid vaccine sars-cov-2 in vitro
LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA
Published: 2020-12-28 (Crawled : 23:00) - biospace.com/
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.24%
H: 0.59%
C: -1.45%
positive cancer fda lung cancer
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.14 57.0% 59M
|
Technology Services
LICN | $0.7885 40.8% 11M
|
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
WHLM | $6.61 30.12% 400K
|
Commercial Services
RILY | $27.91 28.5% 8.9M
|
Finance
RBBN 4 | $3.25 26.46% 1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.